{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:38:04Z","timestamp":1773146284000,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"37-39","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.vaccine.2006.05.028","type":"journal-article","created":{"date-parts":[[2006,6,3]],"date-time":"2006-06-03T11:18:41Z","timestamp":1149333521000},"page":"6332-6339","source":"Crossref","is-referenced-by-count":12,"title":["Immunogenicity of Mycobacterium bovis BCG expressing Anaplasma marginale MSP1a antigen"],"prefix":"10.1016","volume":"24","author":[{"given":"Andr\u00e9","family":"Michelon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabricio Rochedo","family":"Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Canisio","family":"Binsfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Wetzel","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c2ngela Nunes","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Argondizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldo R.G.","family":"Arm\u00f4a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano S.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Farber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnjoe","family":"McFadden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odir Ant\u00f4nio","family":"Dellagostin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.05.028_bib1","series-title":"Infectious tropical diseases of domestic animals","first-page":"473","article-title":"Anaplasmosis","author":"Losos","year":"1986"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.028_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7589\/0090-3558-20.1.12","article-title":"Anaplasma infections in wild and domestic ruminants: a review","volume":"20","author":"Kuttler","year":"1984","journal-title":"J Wildl Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2006.05.028_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1128\/CMR.16.4.698-712.2003","article-title":"Antigens and alternatives for control of Anaplasma marginale infection in cattle","volume":"16","author":"Kocan","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2006.05.028_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0020-7519(00)00162-4","article-title":"Differential adhesion of major surface proteins 1a and 1b of the ehrlichial cattle pathogen Anaplasma marginale to bovine erythrocytes and tick cells","volume":"31","author":"de la Fuente","year":"2001","journal-title":"J Int Parasitol"},{"issue":"2\/3","key":"10.1016\/j.vaccine.2006.05.028_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0378-1135(02)00309-7","article-title":"Characterization of the functional domain of major surface protein 1a involved in adhesion of the rickettsia Anaplasma marginale to host cells","volume":"91","author":"de la Fuente","year":"2003","journal-title":"Vet Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.05.028_bib6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0020-7519(87)90093-2","article-title":"Characterization of a neutralization-sensitive epitope on the Am 105 surface protein of Anaplasma marginale","volume":"17","author":"Palmer","year":"1987","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2006.05.028_bib7","first-page":"285","article-title":"Antibodies to Anaplasma marginale major surface protein 1a reduce infectivity for ticks","volume":"1","author":"de la Fuente","year":"2003","journal-title":"J Appl Res Vet Med"},{"key":"10.1016\/j.vaccine.2006.05.028_bib8_1","series-title":"Tuberculosis: pathogenicity, protection, and control","first-page":"531","article-title":"The BCG experience: implications for future vaccines against tuberculosis","author":"Bloom","year":"1994"},{"issue":"30","key":"10.1016\/j.vaccine.2006.05.028_bib8_2","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1016\/S0264-410X(01)00155-4","article-title":"Recombinant BCG vaccines","volume":"19","author":"Ohara","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.028_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1084\/jem.178.1.197","article-title":"Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine","volume":"178","author":"Stover","year":"1993","journal-title":"J Exp Med"},{"issue":"3\/4","key":"10.1016\/j.vaccine.2006.05.028_bib10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0264-410X(03)00572-3","article-title":"Immune response of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein of porcine reproductive and respiratory syndrome virus","volume":"22","author":"Bastos","year":"2004","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2006.05.028_bib11","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1128\/IAI.72.6.3336-3343.2004","article-title":"Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge","volume":"72","author":"Varaldo","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.05.028_bib12","doi-asserted-by":"crossref","unstructured":"Govan VA, Christensen ND, Berkower C, Jacobs Jr WR, Williamson AL. Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge. Vaccine 2005 [Epub ahead of print].","DOI":"10.1016\/j.vaccine.2005.11.029"},{"key":"10.1016\/j.vaccine.2006.05.028_bib13","series-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"2001"},{"issue":"7","key":"10.1016\/j.vaccine.2006.05.028_bib14","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1128\/JB.183.7.2157-2164.2001","article-title":"Genomic sequence and transcriptional analysis of a 23-kilobase mycobacterial linear plasmid: evidence for horizontal transfer and identification of plasmid maintenance systems","volume":"183","author":"Le Dantec","year":"2001","journal-title":"J Bacteriol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.05.028_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1054\/tube.2002.0374","article-title":"Expression of foreign genes in Mycobacterium bovis BCG strains using different promoters reveals instability of the hsp60 promoter for expression of foreign genes in Mycobacterium bovis BCG strains","volume":"82","author":"Al-Zarouni","year":"2002","journal-title":"Tuberculosis"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2006.05.028_bib16","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1099\/13500872-141-8-1785","article-title":"Activity of mycobacterial promoters during intracellular and extracellular growth","volume":"141","author":"Dellagostin","year":"1995","journal-title":"Microbiology"},{"issue":"8","key":"10.1016\/j.vaccine.2006.05.028_bib17","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1590\/S0100-879X2004000800001","article-title":"A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide","volume":"37","author":"Ramos","year":"2004","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2006.05.028_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1749-6632.2000.tb05329.x","article-title":"Anaplasmosis control. Past, present, and future","volume":"916","author":"Kocan","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.vaccine.2006.05.028_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0304-4017(02)00378-3","article-title":"Antibodies to Anaplasma marginale major surface proteins 1a and 1b inhibit infectivity for cultured tick cells","volume":"111","author":"Blouin","year":"2003","journal-title":"Vet Parasitol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.05.028_bib20","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1128\/IAI.70.10.5521-5532.2002","article-title":"Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a","volume":"70","author":"Brown","year":"2002","journal-title":"Infect Immun"},{"issue":"6326","key":"10.1016\/j.vaccine.2006.05.028_bib21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"issue":"7\/8","key":"10.1016\/j.vaccine.2006.05.028_bib22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0264-410X(98)00255-2","article-title":"Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii","volume":"17","author":"Supply","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.028_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/viro.1999.0131","article-title":"The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins","volume":"268","author":"Leung","year":"2000","journal-title":"Virology"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2006.05.028_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0264-410X(02)00443-7","article-title":"Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus","volume":"21","author":"Bastos","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.05.028_bib25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1139\/w05-095","article-title":"Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin","volume":"51","author":"Medeiros","year":"2005","journal-title":"Can J Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.05.028_bib26","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1128\/IAI.68.9.4877-4883.2000","article-title":"Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice","volume":"68","author":"Nascimento","year":"2000","journal-title":"Infect Immun"},{"issue":"5\/6","key":"10.1016\/j.vaccine.2006.05.028_bib27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.vaccine.2003.08.017","article-title":"Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C","volume":"22","author":"Mazzantini","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2006.05.028_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.vaccine.2005.08.001","article-title":"Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity","volume":"24","author":"Horwitz","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2006.05.028_bib29","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1128\/IAI.69.11.6853-6862.2001","article-title":"CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains","volume":"69","author":"Brown","year":"2001","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.05.028_bib30","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.4049\/jimmunol.166.2.1114","article-title":"Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses","volume":"166","author":"Brown","year":"2001","journal-title":"J Immunol"},{"issue":"3\/4","key":"10.1016\/j.vaccine.2006.05.028_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vetimm.2003.11.003","article-title":"Mapping of B-cell epitopes in the N-terminal repeated peptides of the Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens","volume":"98","author":"Garcia-Garcia","year":"2004","journal-title":"Vet Immunol Immunopath"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.028_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CDLI.6.1.1-5.1999","article-title":"Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens","volume":"6","author":"Buddle","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.05.028_bib33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/CDLI.8.3.571-578.2001","article-title":"Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle","volume":"8","author":"Vordermeier","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"20","key":"10.1016\/j.vaccine.2006.05.028_bib34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/vr.153.20.615","article-title":"Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle","volume":"153","author":"Buddle","year":"2003","journal-title":"Vet Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.028_bib35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.70.1.303-314.2002","article-title":"Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses","volume":"70","author":"M\u00e9derl\u00e9","year":"2002","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06005871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06005871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T06:56:43Z","timestamp":1586933803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06005871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":36,"journal-issue":{"issue":"37-39","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0264410X06005871"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.05.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}